A hidden confounder for microbiome studies: medications used years before sample collection
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Medication usage is a known contributor to the inter-individual variability of the gut microbiome. However, medications are often used repeatedly and for long periods, a notion yet unaccounted for in microbiome studies. Recently, we and others showed that not only the usage of antibiotics and antidepressants at sampling, but also past consumption, is associated with the gut microbiome. This effect can be “additive”—the more a medication is used, the stronger the impact on the microbiome. Here, by utilizing retrospective medication usage data from the electronic health records and the observational Estonian microbiome cohort shotgun metagenomics data set (n = 2,509), we systematically evaluate the long-term effects of antibiotics and human-targeted medications on the gut microbiome. We show that past usage of medications is associated with the gut microbiome. For example, the effects of antibiotics, psycholeptics, antidepressants, proton pump inhibitors, and beta-blockers are detectable several years after use. Furthermore, by analyzing a subcohort (n = 328) with a second microbiome characterization, we show that similar changes in the gut microbiome occur after treatment initiation or discontinuation, possibly indicating causal effects. IMPORTANCE This is the first study using detailed retrospective medication usage data from electronic health records to systematically assess the long-term effects of medication usage on the gut microbiome. We identified carryover and additive…
Overview
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, long-term use of these medications can leave persistent alterations in the gut microbiome that can endure years beyond treatment discontinuation.99”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [99]
Citations
Cites
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
SOAP2: an improved ultrafast tool for short read alignment
Li, R., Yu, C., Li, Y., Lam, T.-W., Yiu, S.-M., Kristiansen, K., & Wang, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp336 · Cited by 3,760
The Statistical Analysis of Compositional Data
Aitchison, J. (1982) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1982.tb01195.x · Cited by 3,405
Population-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A. V., Falony, G., Vieira-Silva, S., et al. (2016) · Science · doi:10.1126/science.aad3369 · Cited by 1,914
Extensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905 · cited 3×
“As antibiotic resistance mechanisms have also been shown to protect against human-targeted drugs (22), this concurrently may affect the abundance of specific microbes in different populations and result in an overall shift in the microbiome composition.”
Wirbel, J., Pyl, P. T., Kartal, E., Zych, K., Kashani, A., Milanese, A., Fleck, J. S., Voigt, A. Y., Palleja, A., Ponnudurai, R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0406-6 · Cited by 1,373 · cited 1×
“As a result, a significant proportion of research is focusing on figuring out how we can use this information for disease diagnostics (6, 7), identifying disease risks (8, 9), and personalization of drug usage (10, 11).”
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota
Jernberg, C., Löfmark, S., Edlund, C., & Jansson, J. K. (2007) · The ISME Journal · doi:10.1038/ismej.2007.3 · Cited by 1,134
Impact of commonly used drugs on the composition and metabolic function of the gut microbiota
Vich Vila, A., Collij, V., Sanna, S., Sinha, T., Imhann, F., Bourgonje, A. R., Mujagic, Z., Jonkers, D. M. A. E., Masclee, A. A. M., Fu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14177-z · Cited by 791
Environmental factors shaping the gut microbiome in a Dutch population
Gacesa, R., Kurilshikov, A., Vich Vila, A., Sinha, T., Klaassen, M. A. Y., Bolte, L. A., Andreu-Sánchez, S., Chen, L., Collij, V., Hu, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04567-7 · Cited by 735
Jackson, M. A., Verdi, S., Maxan, M.-E., Shin, C. M., Zierer, J., Bowyer, R. C. E., Martin, T., Williams, F. M. K., Menni, C., Bell, J. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05184-7 · Cited by 616
Host variables confound gut microbiota studies of human disease
Vujkovic-Cvijin, I., Sklar, J., Jiang, L., Natarajan, L., Knight, R., & Belkaid, Y. (2020) · Nature · doi:10.1038/s41586-020-2881-9 · Cited by 614 · cited 2×
“The drugs belonging to benzodiazepine derivatives are well-known anti-anxiety medications that are often misused and have a high potential for drug abuse (29).”
Microbial abundance, activity and population genomic profiling with mOTUs2
Milanese, A., Mende, D. R., Paoli, L., Salazar, G., Ruscheweyh, H.-J., Cuenca, M., Hingamp, P., Alves, R., Costea, P. I., Coelho, L. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08844-4 · Cited by 446 · cited 2×
“We further focused on the associations between drug usage and the presence-absence (PA) and abundance (centered log-ratio [CLR] transformed) of 530 mOTUs (20), which were prevalent in at least 10% of the cohort.”
Species-specific activity of antibacterial drug combinations
Brochado, A. R., Telzerow, A., Bobonis, J., Banzhaf, M., Mateus, A., Selkrig, J., Huth, E., Bassler, S., Zamarreño Beas, J., Zietek, M., et al. (2018) · Nature · doi:10.1038/s41586-018-0278-9 · Cited by 357
Benzodiazepine Use and Misuse Among Adults in the United States
Maust, D. T., Lin, L. A., & Blow, F. C. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800321 · Cited by 337
A faecal microbiota signature with high specificity for pancreatic cancer
Kartal, E., Schmidt, T. S. B., Molina-Montes, E., Rodríguez-Perales, S., Wirbel, J., Maistrenko, O. M., Akanni, W. A., Alashkar Alhamwe, B., Alves, R. J., Carrato, A., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-324755 · Cited by 290
Misuse of Medicines in the European Union: A Systematic Review of the Literature
Casati, A., Sedefov, R., & Pfeiffer-Gerschel, T. (2012) · European Addiction Research · doi:10.1159/000337028 · Cited by 244
Combinatorial, additive and dose-dependent drug–microbiome associations
Forslund, S. K., Chakaroun, R., Zimmermann-Kogadeeva, M., Markó, L., Aron-Wisnewsky, J., Nielsen, T., Moitinho-Silva, L., Schmidt, T. S. B., Falony, G., Vieira-Silva, S., et al. (2021) · Nature · doi:10.1038/s41586-021-04177-9 · Cited by 226
Nagata, N., Nishijima, S., Miyoshi-Akiyama, T., Kojima, Y., Kimura, M., Aoki, R., Ohsugi, M., Ueki, K., Miki, K., Iwata, E., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.070 · Cited by 178
Taxonomic signatures of cause-specific mortality risk in human gut microbiome
Salosensaari, A., Laitinen, V., Havulinna, A. S., Meric, G., Cheng, S., Perola, M., Valsta, L., Alfthan, G., Inouye, M., Watrous, J. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22962-y · Cited by 171
Population-level impacts of antibiotic usage on the human gut microbiome
Lee, K., Raguideau, S., Sirén, K., Asnicar, F., Cumbo, F., Hildebrand, F., Segata, N., Cha, C., & Quince, C. (2023) · Nature Communications · doi:10.1038/s41467-023-36633-7 · Cited by 161
Lewer, D., O'Reilly, C., Mojtabai, R., & Evans-Lacko, S. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156786 · Cited by 150
Liu, Y., Méric, G., Havulinna, A. S., Teo, S. M., Åberg, F., Ruuskanen, M., Sanders, J., Zhu, Q., Tripathi, A., Verspoor, K., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.03.002 · Cited by 104
Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017
Bruyndonckx, R., Adriaenssens, N., Versporten, A., Hens, N., Monnet, D. L., Molenberghs, G., Goossens, H., Weist, K., Coenen, S., the ESAC-Net study group, et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab172 · Cited by 76
Heterogeneity in statin responses explained by variation in the human gut microbiome
Wilmanski, T., Kornilov, S. A., Diener, C., Conomos, M. P., Lovejoy, J. C., Sebastiani, P., Orwoll, E. S., Hood, L., Price, N. D., Rappaport, N., et al. (2022) · Med · doi:10.1016/j.medj.2022.04.007 · Cited by 72
Emergence of community behaviors in the gut microbiota upon drug treatment
García‐Santamarina, S., Kuhn, M., Devendran, S., Maier, L., Driessen, M., Mateus, A., Mastrorilli, E., Brochado, A. R., Savitski, M. M., Patil, K. R., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.037 · Cited by 70
Aasmets, O., Krigul, K. L., Lüll, K., Metspalu, A., & Org, E. (2022) · Nature Communications · doi:10.1038/s41467-022-28464-9 · Cited by 61
Self-citationLukačišinová, A., Reissigová, J., Hadžiabdić, M. O., Brkić, J., Okuyan, B., Volmer, D., Tadić, I., Modamio, P., Mariño, E. L., Tachkov, K., et al. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04742-7 · Cited by 58
Long-term life history predicts current gut microbiome in a population-based cohort study
Si, J., Vázquez-Castellanos, J. F., Gregory, A., Decommer, L., Rymenans, L., Proost, S., Centelles-Lodeiro, J., Weger, M., Notdurfter, M., Leitner, C., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00286-w · Cited by 49
A history of repeated antibiotic usage leads to microbiota-dependent mucus defects
Krigul, K. L., Feeney, R. H., Wongkuna, S., Aasmets, O., Holmberg, S. M., Andreson, R., Puértolas-Balint, F., Pantiukh, K., Sootak, L., Org, T., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2377570 · Cited by 26
Self-citationBrusselaers, N., Pereira, M., Alm, J. S., Engstrand, L. G., & Lilja, H. E. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00518-9 · Cited by 19
Kurvits, K., Toompere, K., Jaanson, P., & Uusküla, A. (2024) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-024-00757-5 · Cited by 11
Antibiotic use in the past 8 years and gut microbiota compositionPreprint
Baldanzi, G., Larsson, A. H., Sayols-Baixeras, S., Dekkers, K. F., Hammar, U., Nguyen, D. T., Graells, T., Ahmad, S., Volpiano, C. G., Méric, G., et al. (2024) · medRxiv · doi:10.1101/2024.10.14.24315441 · Cited by 5
Research works printed but not linked: 1
- 10.1046/j.1442-9993.2001.01070.x · DOI · Paper page
Cited by
Gut dysbiosis in oncology: a risk factor for immunoresistance
(2026) · doi:10.1038/s41422-025-01212-6 · Cited by 24
Metadata
- Authors
- Aasmets, O., Taba, N., Krigul, K. L., Andreson, R., Estonian Biobank Research Team, Org, E., Metspalu, M., Metspalu, A., Milani, L., & Esko, T.
- Affiliations
- University of Tartu (EE)
- Corresponding author
- Aasmets, Oliver
- Org, Elin
- ORCID
- Venue
- mSystems
- Publisher
- American Society for Microbiology
- Published
- 2025-10-22
- Volume
- 10
- Issue
- 10
- Pages
- e0054125-e0054125
- ISSN
- 2379-5077 (ISSN-L)
- PMC
- PMC12542737
- OpenAlex
- W4414017107
- Cited by
- 30
- References
- 35
- Citations by year
- 2026: 27 · 2025: 3
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mSystems (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Eesti Teadusagentuur (PRG1414)
- European Molecular Biology Organization (Installation grant 3573)
- Biocodex Microbiota Foundation
- Estonian Center of Genomics/Roadmap II (16-0125)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, chronic drug administration, confounding, residual effects, additive effects, antibiotics, antidepressants, psycholeptics, benzodiazepines, glucocorticoids, proton pump inhibitors, beta-blockers, electronic health records
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Anti-Bacterial Agents, Antidepressive Agents, Female, Humans, Male, Middle Aged, Retrospective Studies, Metagenomics, Electronic Health Records, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.